Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Felsner, P; Steinschifter, W; Fischer, M; Eferl, R; Kenner, L; Zatloukal, K; Lahousen, M; Liebmann, PM; Schauenstein, E; Schauenstein, K.
The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignancies.
Cancer. 2000; 88(2):461-467 Doi: 10.1002/(SICI)1097-0142(20000115)88:2<461::AID-CNCR29>3.0.CO;2-V [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Schauenstein Konrad
Co-Autor*innen der Med Uni Graz
Kenner Lukas
Lahousen Manfred
Liebmann-Holzmann Peter
Zatloukal Kurt
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: Previously, it could be demonstrated that human patients with malignant diseases of various tissues exhibited characteristic and highly significant changes in the serum patterns of immunoglobulin (Ig)G subclasses, consisting of a decrease in IgG1 and an increase in IgG2 relative to total IgG. The aim of the current study was to determine whether this phenomenon was detectable at the level of IgG-producing B lymphocytes. METHODS: Using a competitive reverse transcriptase polymerase chain reaction specific to IgG1 and IgG2, the gene expression of these 2 IgG subclasses in peripheral B cells from 10 patients with carcinomas of various sites within the female reproductive tract and 10 healthy controls was quantitatively determined, in parallel with the concentrations of the respective serum proteins. RESULTS: Absolute levels of IgG subclass messenger ribonucleic acid (mRNA) showed a slight but not significant decrease in IgG1 and an increase in IgG2 in patients with gynecologic malignancies. However, the ratio of IgG1 to IgG2 expression showed a highly significant (P < 0.001) decrease in tumor patients compared with healthy controls, and corresponded to the change in the ratio of IgG1 to IgG2 serum proteins. CONCLUSIONS: These data suggest that the shifts in the serum patterns of IgG1 and IgG2 observed in patients with gynecologic malignancies are due to irregular biosynthesis of these IgG subclasses at the B-cell level.
Find related publications in this database (using NLM MeSH Indexing)
B-Lymphocytes - immunology
DNA Primers - immunology
Female - immunology
Gene Expression Regulation, Neoplastic - immunology
Genital Neoplasms, Female - genetics
Humans - genetics
Immunoglobulin G - biosynthesis
Middle Aged - biosynthesis
RNA, Messenger - genetics
Reverse Transcriptase Polymerase Chain Reaction - genetics

Find related publications in this database (Keywords)
tumor-immune system relations
immunoglobulin G sublasses
tumor marker
immunoglobulin gene expression
quantitative reverse transcriptase-polymerase
chain reaction
© Med Uni Graz Impressum